Racial disparities in treatment preferences for rheumatoid arthritis
about
Measuring preferences for analgesic treatment for cancer pain: how do African-Americans and Whites perform on choice-based conjoint (CBC) analysis experiments?Does the "Hispanic paradox" occur in rheumatoid arthritis? Survival data from a multiethnic cohort.Racial and ethnic disparities in disease activity in patients with rheumatoid arthritis.Understanding why rheumatoid arthritis patient treatment preferences differ by race.Perceived barriers to integrated care in rheumatoid arthritis: views of recipients and providers of care in an inner-city setting.Factors associated with initial or subsequent choice of biologic disease-modifying antirheumatic drugs for treatment of rheumatoid arthritis.Can racial disparities in optimal gout treatment be reduced? Evidence from a randomized trialAfrican American patients with gout: efficacy and safety of febuxostat vs allopurinol.Subjective numeracy and preference to stay with the status quo.Ethnic and racial factors influencing well-being, perceived pain, and physical function after primary total joint arthroplasty.Racial and ethnic disparities in disease activity and function among persons with rheumatoid arthritis from university-affiliated clinics.The design of a low literacy decision aid about rheumatoid arthritis medications developed in three languages for use during the clinical encounter.Persisting Racial Disparities in Total Shoulder Arthroplasty Utilization and OutcomesRacial and gender disparities among patients with gout.Examining Hepatitis C Virus Treatment Preference Heterogeneity Using Segmentation Analysis: Treat Now or Defer?Factors Contributing to the Preference of Korean Patients with Crohn's Disease When Selecting an Anti-Tumor Necrosis Factor Agent (CHOICE Study)Openness to and preference for attributes of biologic therapy prior to initiation among patients with rheumatoid arthritis: patient and rheumatologist perspectives and implications for decision makingPatient preferences and satisfaction in the treatment of rheumatoid arthritis with biologic therapy.The clinical spectrum of juvenile idiopathic arthritis in a large urban population.Racial and ethnic disparities in rheumatoid arthritis.Economics of stratified medicine in rheumatoid arthritis.How important is mode of administration in treatments for rheumatic diseases and related conditions?Patient-reported outcomes in Asia: evaluation of the properties of the Rheumatoid Arthritis Impact of Disease (RAID) score in multiethnic Asian patients with rheumatoid arthritis.Disparities in Access to Outpatient Rehabilitation Therapy for African Americans with Arthritis.Variation in Treatment Priorities for Chronic Hepatitis C: A Latent Class Analysis.Treatment preferences of patients with early rheumatoid arthritis: a discrete-choice experiment.Patient weighting of osteoporosis medication attributes across racial and ethnic groups: a study of osteoporosis medication preferences using conjoint analysis.Racial/ethnic differences in the use of biologic disease-modifying antirheumatic drugs among California Medicaid rheumatoid arthritis patients.Understanding the factors that influence risk tolerance among minority women: A qualitative study.Variability in Affect and Willingness to Take Medication.Baricitinib in Patients with Rheumatoid Arthritis and an Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs in United States and Rest of World: A Subset Analysis.
P2860
Q28659121-248F48A5-996E-4A0A-9D38-13EDA65BF5A2Q30715768-29E14593-FAAF-4999-AC83-580B35F348F5Q33551313-CBF98CC0-A551-49F9-A27F-575B20F721C8Q33773264-D5D3FE9D-D227-4FB5-8708-00D1B70A99FEQ33795253-3B426F8A-5427-4873-988C-3095C8BCDBDEQ33876980-3D6B9ECB-FA2E-45E4-9781-6606309FF94FQ34153529-9B09FB6B-344A-48BC-9675-CD043C38BB01Q34153554-4118BC03-ECAB-48ED-9C4A-D56DE9E20EF9Q34395303-7AA0C924-53A5-47C6-B4E7-BA5ACB6E5BEAQ35036576-7BCF6E61-54BE-4AAA-94DE-5B65F6ECDBE3Q35204743-394F5FF1-182D-414B-8AD4-43A2948557A4Q35554857-F91E1EA1-DD2C-49DD-8E23-32B35B010446Q36090386-14691B84-7A84-4F99-B85D-F44712FD4EA8Q36533940-8CB36C82-AFC5-46F4-85D7-E67E784789D6Q36738517-C233CCE0-D84F-4848-AA91-8EE94BD1B176Q36848945-D8B5966C-4D42-42A3-B1FB-7777091B1529Q37021279-06052342-6C77-4709-B831-1F463DDD2948Q37473766-383FB314-24B7-4A19-A2E2-8CCB676327A2Q37981131-2AC534F3-7787-4F33-A1C5-E3E0F49408CEQ38024756-71F8A3B0-582B-4F66-A075-DECCAD4265A0Q38264743-6C57EB9B-B335-4651-BB3F-29FFABE04A2AQ38436502-5791FF3B-65C9-4E5B-B029-4031769B4A82Q39048368-16688C52-D948-4FDF-B4AD-2DD95B7FF9EEQ39613579-8382B790-6E42-46C5-9686-B672EBE171B7Q40374302-FC064D20-E47B-42FD-A0C9-76FADF6E35DCQ40593579-9CA0FDCE-B472-4AB3-BDB7-9BBA8896FC4DQ44954320-1B133567-5A10-441F-9F1D-C8298410C14DQ46460604-626657BB-616D-429E-AECB-9BA7CCC3EC5AQ50041214-8CFC5880-2123-4B5A-89D5-023F5F532E7EQ50275941-A3445F93-A8B9-4DB3-AF61-F388861D8CC4Q55251974-33747C96-4C18-499A-ABAA-F984FAACD675
P2860
Racial disparities in treatment preferences for rheumatoid arthritis
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Racial disparities in treatment preferences for rheumatoid arthritis
@en
type
label
Racial disparities in treatment preferences for rheumatoid arthritis
@en
prefLabel
Racial disparities in treatment preferences for rheumatoid arthritis
@en
P2093
P2860
P1433
P1476
Racial disparities in treatment preferences for rheumatoid arthritis
@en
P2093
Arthur Weinstein
Liana Fraenkel
Suzanne Goucher
P2860
P304
P356
10.1097/MLR.0B013E31818AF829
P577
2009-03-01T00:00:00Z